NCT01142076

Xinju Xiaogao Prescription Study on Overweight

Xinju Xiaogao Prescription and 10% of it in the Treatment of Adiposity (Stagnation of QI Causing Phlegm Retention)Clinical Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 140 (actual)
• Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Xinju Xiaogao prescription and 10% of it in the treatment of adiposity (stagnation of QI causing phlegm retention)clinical study

Detailed description

Charged by the three research centers in line with traditional Chinese medicine stagnation of QI causing phlegm retention 120 cases have diabetes were randomly divided into Chinese herbal compound Xinju Xiaogao prescription group and 10% of the prescription group.The treatment groups were compared 24-week step-down and regulation of body weight,waistline, blood lipids, blood sugar effect.

Conditions

• Overweight

Interventions

Type	Name	Description
DRUG	Xinju Xiaogao Prescription	treatment group
DRUG	placebo	Therapeutic dose of 10%

Timeline

• Start date: 2010-06-01
• Primary completion: 2011-02-01
• Completion: 2011-03-01
• First posted: 2010-06-11
• Last updated: 2013-12-11